Hotflash inc

Hotflash inc

Share this post

Hotflash inc
Hotflash inc
Hotflash inc #116: Research, research, research

Hotflash inc #116: Research, research, research

It's like March madness, except in October and with menopause

Hotflash Inc's avatar
Hotflash Inc
Oct 08, 2022
∙ Paid
3

Share this post

Hotflash inc
Hotflash inc
Hotflash inc #116: Research, research, research
Share

It’s that time of year: the North American Menopause Society is holding their annual meeting this week from Monday, October 12-15 in Atlanta, Georgia. 

There is so much research to be presented that I wish I had a team of writers and the resources to publish their findings, but rest assured I’ll be following up on as many of these as I possibly can.

• One presentation that should bring a lot of things together in the area of hot flashes comes from Dr Susan Reed, professor and vice-chair of the department of obstetrics and gynecology at the University of Washington School of Medicine. She’s going to present on the status of developing treatments for vasomotor symptoms (VMS), both hormonal and non-hormonal, covering everything from pricing to how women can go about choosing their options. As has been covered in Hotflash inc previously, there is a new, non-hormone therapy for hot flashes currently awaiting FDA approval: neurokinin B (NKB) antagonists. Although the insane truth is that we …

Keep reading with a 7-day free trial

Subscribe to Hotflash inc to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Hotflash inc
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share